Exact Sciences Corporation (NASDAQ:EXAS) reported better-than-expected third-quarter financial results and raised its FY25 sales guidance above estimates on Monday.Exact Sciences reported quarterly earnings of 24 cents per share which beat the analyst consensus estimate of a loss of 7 cents per share. The company reported quarterly sales of $850.739 million which beat the analyst consensus estimate of $810.178 million.Exact Sciences raised its FY2025 sales guidance from $3.130 billion-$3.170 billion to $3.2 ...